Pharma BD Deal Intelligence
J&J paid $4.325B for Abbott Medical Optics—a divestiture forced by Abbott's St. Jude acquisition—gaining a vision care portfolio spanning cataract surgery, LASIK, and consumer eye health. The deal expanded J&J Vision's surgical capabilities beyond contact lenses into higher-margin devices.
J&J acquired Abbott Medical Optics for $4.325B for vision care products.
J&J completed the acquisition of Abbott Medical Optics, with the combined organization operating under the brand name Johnson & Johnson Vision,…
Source summaries from our enrichment pipeline; follow links for originals.
All 4 sources with sentiment breakdown →
J&J acquired Abbott Medical Optics for $4.325B for vision care products.
3.7M US cases/yr · $7.2B Global Ophthalmic Surgical Devices (2016) · 3.7M US Cataract Surgeries/Year
Abbott Medical Optics specialized in cataract surgery equipment, IOLs, and LASIK technology. Cataract surgery volumes were growing 3-4% annually with an aging global population.
J&J created Johnson & Johnson Vision, combining AMO's surgical portfolio with Acuvue contacts, forming the world's most comprehensive vision care company.
J&J completed $4.325B acquisition of Abbott Medical Optics from Abbott Laboratories, gaining cataract, LASIK, and consumer vision care product lines.
AMO fully integrated into J&J Vision, strengthening position as comprehensive eye health company across surgical and consumer segments.
AMO reinforced J&J Vision's market-leading position in surgical ophthalmology. Generates steady revenue within J&J MedTech segment.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Johnson & Johnson / Abbott Medical Optics (this deal) | 2003 | $4.3B | 70 |
| Johnson & Johnson / Legend Biotech Corporation | 2017 | $9.0B | 96 |
| Johnson & Johnson / Centocor Inc. | 1999 | $4.9B | 92 |
| Johnson & Johnson / Cougar Biotechnology, Inc. | 2009 | $970M | 91 |
| Johnson & Johnson / Actelion Ltd | 2017 | $30.0B | 90 |
| Johnson & Johnson / Aragon Pharmaceuticals Inc. | 2013 | $1.0B | 89 |
| Johnson & Johnson / Legend Biotech Corporation | 2017 | $350M | 83 |
← Browse all deals · How we score deals
More: 2003 deals · Johnson & Johnson deals · Ophthalmology deals